Patent · US Active

CD37-binding molecules and immunoconjugates thereof

US10202460B2 · kind B2 · utility

5Cited by

9References

22Claims

0Family size

Assignee

Debiopharm International S.A.

Inventors

Jutta Deckert · Lexington, US
Peter U. Park · Lexington, US
Daniel Tavares · Natick, US
Lingyun Rui · Weston, US

Key dates

Filing date	Apr 15, 2016
Grant date	Feb 12, 2019
Priority date	—
Expiry date	Apr 15, 2036

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/70596
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Novel anti-cancer agents, including, but not limited to, antibodies and immunoconjugates, that bind to CD37 are provided. Methods of using the agents, antibodies, or immunoconjugates, such as methods of inhibiting tumor growth are further provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.